Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.09 per share when it actually produced earnings of $0.14, delivering a surprise of 55.56%.Over the last four ...